Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

  • A
    Transfused cells have a limited life span
  • B
    Introduced gene has been mutated
  • C
    The enzyme required is degraded after $20$ days of transfusion
  • D
    Both $(a)$ and $(c)$

Explore More

Similar Questions

Which of these is used as a vector in gene therapy for $SCID$?

The two polypeptides of human insulin are linked together by

List the advantages of recombinant insulin.

Which of the following is used for the treatment of genetic disorders?

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo